BREAST INFLAMMATORY CARCINOMA
Clinical trials for BREAST INFLAMMATORY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BREAST INFLAMMATORY CARCINOMA trials appear
Sign up with your email to follow new studies for BREAST INFLAMMATORY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Vaccine aims to block return of aggressive breast cancer
Disease control OngoingThis phase 2 trial tests whether a vaccine made from a protein found on many triple-negative breast cancer cells can help prevent the cancer from coming back. Participants receive the vaccine along with an immune booster and a low dose of chemotherapy. The study includes women wi…
Matched conditions: BREAST INFLAMMATORY CARCINOMA
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New combo therapy aims to fight rare, aggressive breast cancer
Disease control OngoingThis study is for people with inflammatory breast cancer, a rare and aggressive type, who have already had chemotherapy and surgery. It tests whether adding the drug olaparib to standard radiation therapy helps keep the cancer from coming back. About 300 participants will be rand…
Matched conditions: BREAST INFLAMMATORY CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Immunotherapy boost for tough breast cancer
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to standard hormone therapy can help prevent recurrence in people with a rare, aggressive type of breast cancer called inflammatory breast cancer. Participants had hormone receptor-positive cancer that did not f…
Matched conditions: BREAST INFLAMMATORY CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC